Literature DB >> 29532217

Z-LASIK and Trans-PRK for correction of high-grade myopia: safety, efficacy, predictability and clinical outcomes.

Assaf Gershoni1,2,3, Michael Mimouni4, Eitan Livny1,2,3, Irit Bahar5,6,7.   

Abstract

PURPOSE: The aim of the study was to examine the outcomes of transepithelial photorefractive keratectomy (Trans-PRK) and Femtosecond Laser-assisted in situ keratomileusis (Z-LASIK) for the correction of high myopia.
METHODS: A retrospective cohort study design was used. The study group included 792 eyes with high-grade myopia (- 6.0 diopters or higher) or high-grade myopia with astigmatism that were treated with Z-LASIK or Trans-PRK in 2013 through 2014 in an optical outpatient clinic of a large private medical service. The Trans-PRK group comprised of 674 eyes with a spherical equivalent (SE) of - 7.87 ± 1.46 and the Z-LASIK group comprised of 118 eyes with a SE of - 7.19 ± 0.81 (P < 0.001).
RESULTS: The mean postoperative SE in the Trans-PRK group was - 0.06 and - 0.02 in the Z-LASIK group (P = 0.545). Efficacy index values were 0.92 in the Trans-PRK group and 0.95 in the Z-LASIK group (P = 0.083), and corresponding safety index values were 0.95 and 0.97 (P = 0.056). An UCVA of 20/40 or better was achieved in 94.20% of eyes in the Trans-PRK group, and 98.31% in the Z-LASIK group (P = 0.063). The majority of eyes in both the Trans-PRK and Z-LASIK groups were within ± 0.5D of attempted correction: 59.35 and 64.71%, respectively (P = 0.271).
CONCLUSIONS: Both Trans-PRK and Z-LASIK demonstrated excellent efficacy, safety and predictability profiles, with results comparable and in some cases superior to the current literature. Results of Z-LASIK were slightly better than those of Trans-PRK, though the preoperative SE of the latter was higher.

Entities:  

Keywords:  Efficacy; FS-LASIK; High myopia; Predictability; Refractive surgery; Safety; Trans-PRK

Mesh:

Year:  2018        PMID: 29532217     DOI: 10.1007/s10792-018-0868-4

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  5 in total

1.  Post-refractive surgery of Israeli Defense Forces recruits in 2005-2018-prevalence, combat unit drop-out rates and utilization of eye-care services.

Authors:  Eran Greenbaum; Edward Barayev; Sagi Shpitzer; Dan Heller; Yoav Nahum; Eitan Livny; Assaf Gershoni; Irit Bahar
Journal:  Eye (Lond)       Date:  2022-07-14       Impact factor: 4.456

2.  Comparison of clinical results between trans-PRK and femtosecond LASIK for correction of high myopia.

Authors:  Jiafan Zhang; Qingqing Feng; Wenzhi Ding; Yusu Peng; Keli Long
Journal:  BMC Ophthalmol       Date:  2020-06-19       Impact factor: 2.209

Review 3.  Preferred practice patterns for photorefractive keratectomy surgery.

Authors:  Rajesh Fogla; Gaurav Luthra; Aishwarya Chhabra; Krati Gupta; Ritika Dalal; Pooja Khamar
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

4.  Twelve-Month Outcomes of the Wavefront-Optimized Photorefractive Keratectomy for High Myopic Correction Compared with Low-to-Moderate Myopia.

Authors:  Napaporn Tananuvat; Pawara Winaikosol; Muanploy Niparugs; Winai Chaidaroon; Chulaluck Tangmonkongvoragul; Somsanguan Ausayakhun
Journal:  Clin Ophthalmol       Date:  2021-12-22

5.  Efficacy and safety of single-step transepithelial photorefractive keratectomy with the all-surface laser ablation SCHWIND platform without mitomycin-C for high myopia: A retrospective study of 69 eyes.

Authors:  Jean Baptiste Giral; Florian Bloch; Maxime Sot; Yinka Zevering; Arpine El Nar; Jean Charles Vermion; Christophe Goetz; Louis Lhuillier; Jean-Marc Perone
Journal:  PLoS One       Date:  2021-12-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.